Prof Julie Redfern
Director & Research Professor, IEBH
Institute for Evidence-Based Healthcare, Building 5, Level 4
Accepting PhD StudentsContact details
Professional biography
Professor Julie Redfern AM PhD FAAHMS FESC GAICD is a Professor of Public Health and Director of the Institute for Evidence-Based Healthcare at Bond University. Professor Redfern currently holds a NHMRC Investigator Grant Leadership 2 (winner of NHMRC Elizabeth Blackburn Award for Health Services). She is also a Physiotherapist, and Adjunct Professor in Sydney Nursing School Faculty of Medicine and Health, University of Sydney. Professor Redfern is a Fellow of the Australian Academy of Health and Medical Sciences (FAAHMS) and the European Society of Cardiology (FESC).
Awards
- Australian Cardiovascular Alliance Mentor Award, 2023
- NSW Woman of Excellence Award, 2022
- NHMRC Elizabeth Blackburn Investigator Grant Award (Leadership in Health Services), 2021
- University of Sydney Vice Chancellor's Award for Leadership and Mentoring, 2021
- Australian Clinical Trials Alliance Consumer Involvement Award (EMPOWER-SMS trial), 2022
- Finalist, Research Australia Data Innovation Awards (QUEL trial), 2023
- NSW Surf Life Saving Volunteer of the year, 2022 and as Director of Administration led her club to win the highly prestigious Australian Surf Life Saving Club of the year, 2024
- Vice-Chancellor’s Award, Leadership and Mentoring, University of Sydney, 2021
- Sydney University Postgraduate Representative Association (SUPRA) Supervisor of the Year, 2017
- NSW Tall Poppy, Australian Institute of Policy and Science, 2009
- Best New Researcher, Australian Physiotherapy Association (Cardiorespiratory), 2007
- Best Research Presentation, Australian Cardiac Rehabilitation Association, 2007
- Affiliates Prize, CSANZ 54th Annual Scientific Meeting, 2006
National and international leadership
Professor Redfern is a current member of the Board of the World Heart Federation, a previous Emerging Leader (2015) and Member of the Science Committee (2022-2024). She is currently a member of the Scientific Committee of the Cardiac Society of Australia and New Zealand (CSANZ) and previously served a 6-year term on the CSANZ Board as Chair of the Allied Health and Technology Council. She is also the current Chair of the Australian Cardiovascular Alliance (ACvA) Scientific Advisory Committee and co-Director of the Implementation and Policy Flagship.
Mentoring and supervision
Professor Redfern's mentoring and supervision includes >26 postdocs and >21 HDR students with many having been successful with NHMRC Investigator Grants, Heart Foundation Fellowships and prestigious Awards such as the Eureka Prize for Emerging Leader in Science (Dr Stephanie Partridge, Dr Stephanie Partridge (sydney.edu.au)) and NSW Cancer Council Outstanding Early Career Researcher (Dr Anna Singleton Dr Anna Singleton (sydney.edu.au)). She has also been a formal mentor for the AAHMS, Franklin Women and European Society of Cardiology (ESC) Mentoring Programs. Professor Redfern was also Research Academic Director (0.2FTE), Researcher Development in the Faculty of Medicine and Health, University of Sydney for 4 years.
Research interests
Professor Redfern AM has been a CI on research grants totalling $30M in the past 5 years and has published over 280 manuscripts and 4 book chapters. She has >15 years of experience developing, testing and implementing scalable strategies to close evidence-practice gaps and improve health outcomes for people with chronic disease. She also has expertise in multidisciplinary and translational research and is an advocate for effective secondary prevention of cardiovascular disease and her research interest is focused on improving clinical practice and reduction of risk factors ultimately in people with a range of chronic diseases.
Professor Redfern has Chaired the Steering Committee for 12 projects (8 clinical trials, 4 cohorts) recruiting >24,000 patients. This inlcudes the QUEL cluster RCT in primary care along with systematic reviews related to improved secondary prevention of heart disease and led the team that won 2022 ACTA Trial of the year for consumer involvement. Professor Redfern’s research program also includes evaluation of peer support strategies, breast cancer survivorship, respiratory disease, data-driven care in primary and outpatient care and digital health.
Professor Redfern leads the SOLVE-CHD program (HOME - solvechd.org.au). The SOLVE-CHD program is supporting capacity building for multidisciplinary research team of researchers and clinicians with allied health, nursing, cardiology, public health, health economics and psychology backgrounds. The goal is to transform post-discharge secondary prevention and reduce the burden of heart disease by decreasing deaths, hospitalisations and costs via a program of work that integrates data, technology, partnerships and capacity building. SOLVE-CHD program includes implementation of a national cardiac rehabilitation excellence and clinician training initiative along with a global transformative initiative supported by the World Heart Federation.
Professional admissions
- Member of the Order of Australia (AM)
- Fellow of the Australian Academy of Health and Medical Sciences (FAAHMS)
- Fellow of the European Society of Cardiology (FESC)
- Graduate, Australian Institute of Company Directors (GAICD)
Professional appointments
- Board Member, World Heart Federation, 2025 - current
- Member, NHMRC-MRFF Joint Advisory Committees -Public Health and Health Systems Committee, 2025-31st October 2027
- Co-Chair, World Heart Federation Forum Sex Differences and CVD, 2024-current
- Co-Chair, Scientific Program Committee, CSANZ ASM, 2025 CSANZ 2025 - 73rd Annual Scientific Meeting of the Cardiac Society in Brisbane, Australia - CSANZ 2025
- Previous Member, World Heart Federation Science Committee, 2022-2024 https://world-heart-federation.org/our-committees/science-committee/
- Member, NHFA/CSANZ Australian ACS Guidelines Expert Writing Group, 2023-current
- Member, CSANZ Scientific Committee, 2022-current https://www.csanz.edu.au/
- Alan Goble Oration for ACRA ASM, 2022
- Allied Health Science and Technology Lecture, CSANZ ASM, 2022
- Co-Chair, CSANZ Clinical and Preventive Cardiology Council https://www.csanz.edu.au/
- Co-Director, Australian Cardiovascular Alliance (ACvA) Flagship https://ozheart.org/, 2020-current
- Member, CSANZ Board of Directors for Education Trust, 2017-current
- Member, Queensland CVRN Executive Steering Committee https://www.heartfoundation.org.au/research/queensland-cvrn, 2024-current
- Associate Editor, npj Digital Medicine, 2020-current https://www.nature.com/npjdigitalmed/editors
- Editorial Board Member, Heart Lung Circulation, 2028-current
- Previous Member CSANZ Board and Chair of Allied Health and Technology Council, 2010-2016
- Previous, World Heart Federation Emerging Leaders Programme, 2015
Qualifications
- PhD, University of Sydney
- BAppSc (Physiotherapy) Hons 1, University of Sydney
- BSc (Anatomy and Physiology), University of Sydney
Fields of Research
- Cardiovascular medicine and haematology
- Health services and systems